WHO Says Likely to Receive Clarifications from Bharat Biotech on Covaxin by Weekend
The Technical Advisory Group met October 26 and decided that additional clarifications from Bharat Biotech are needed to conduct a final EUL risk-benefit assessment for global use of the Covaxin vaccine.